Dr. Ian Armstrong

Head of Formulation Development

Ian is a pharmacist with a PhD in pharmaceutical drug delivery from the University of Nottingham. He has more than 25 years of experience in formulation development covering pharmaceutical (Wyeth and Shire), consumer healthcare (Wyeth Consumer Healthcare) and medical device compounds (Futura Medical). He has led projects across the whole product development cycle, from candidate selection, through Phase 1-3 development, to post approval life cycle management. He has experience of working across a variety of different dosage forms, both in an in-house, as well as in an out-sourced model of development. Ian joined the ReViral team in May 2020 to head the formulation efforts on the fusion inhibitor and N-protein inhibitor programs.